Ringpu BioTech to reduce registered capital by repurchasing shares

Tianjin Ringpu Bio-Technology (SZSE:300119) announced plans to reduce its registered capital by repurchasing and canceling 1,093,200 restricted shares, representing 0.2347% of the company's total share capital. The decision follows the approval of resolutions at the company's board and supervisory meetings on April 1, 2025, and subsequently ratified by the shareholder meeting on April 24, 2025. The repurchased shares include 39,000 shares from departing employees and 1,054,200 shares due to the company not meeting performance targets. Post-cancellation, the total share capital will decrease from 465,847,906 to 464,754,706 shares, and the registered capital will be reduced from CNY 46,584,790.6 to CNY 46,475,470.6. Creditors are entitled to claim debt repayment or request corresponding security within 45 days from the announcement date.